MedPath

Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI:RCT

Not Applicable
Conditions
Infertility Assisted reproduction
Registration Number
PACTR201704002212265
Lead Sponsor
Airforce specialized hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
106
Inclusion Criteria

Regular menstrual cycle (21-35 days duration),
- body mass index (BMI) less than 30 kg/m2
- poor ovarian response according to Bologna Criteria

Exclusion Criteria

- systemic disease e.g. diabetes or endocrinal disease e.g. polycystic ovaries
- uterine pathology e.g. submucous fibroid polyp or fibroid, and those male factor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of retrieved oocytes
Secondary Outcome Measures
NameTimeMethod
Fertilization rate;Metaphase II oocytes;Embryo quality;Number of transferred embryos;Pregnancy rate;Miscarriage rate
© Copyright 2025. All Rights Reserved by MedPath